Altria (NYSE:MO) Surprises With Strong Q1

StockStory
04-29
Altria (NYSE:MO) Surprises With Strong Q1

Tobacco company Altria (NYSE:MO) announced better-than-expected revenue in Q1 CY2025, with sales up 11.5% year on year to $5.26 billion. Its non-GAAP profit of $1.23 per share was 3.5% above analysts’ consensus estimates.

Is now the time to buy Altria? Find out in our full research report.

Altria (MO) Q1 CY2025 Highlights:

  • Revenue: $5.26 billion vs analyst estimates of $4.64 billion (11.5% year-on-year growth, 13.5% beat)
  • Adjusted EPS: $1.23 vs analyst estimates of $1.19 (3.5% beat)
  • Operating Margin: 34%, down from 56.7% in the same quarter last year
  • Market Capitalization: $98.13 billion

“Our highly profitable traditional tobacco businesses performed well in a challenging environment in the first quarter,” said Billy Gifford, Altria’s Chief Executive Officer.

Company Overview

Best known for its Marlboro brand of cigarettes, Altria (NYSE:MO) offers tobacco and nicotine products.

Sales Growth

Reviewing a company’s long-term sales performance reveals insights into its quality. Any business can experience short-term success, but top-performing ones enjoy sustained growth for years.

With $20.99 billion in revenue over the past 12 months, Altria is one of the most widely recognized consumer staples companies. Its influence over consumers gives it negotiating leverage with distributors, enabling it to pick and choose where it sells its products (a luxury many don’t have). However, its scale is a double-edged sword because there are only a finite number of major retail partners, placing a ceiling on its growth. To expand meaningfully, Altria likely needs to tweak its prices, innovate with new products, or enter new markets.

As you can see below, Altria struggled to increase demand as its $20.99 billion of sales for the trailing 12 months was close to its revenue three years ago. This shows demand was soft, a tough starting point for our analysis.

This quarter, Altria reported year-on-year revenue growth of 11.5%, and its $5.26 billion of revenue exceeded Wall Street’s estimates by 13.5%.

Looking ahead, sell-side analysts expect revenue to decline by 3.5% over the next 12 months, a deceleration versus the last three years. This projection is underwhelming and suggests its products will see some demand headwinds. At least the company is tracking well in other measures of financial health.

Today’s young investors likely haven’t read the timeless lessons in Gorilla Game: Picking Winners In High Technology because it was written more than 20 years ago when Microsoft and Apple were first establishing their supremacy. But if we apply the same principles, then enterprise software stocks leveraging their own generative AI capabilities may well be the Gorillas of the future. So, in that spirit, we are excited to present our Special Free Report on a profitable, fast-growing enterprise software stock that is already riding the automation wave and looking to catch the generative AI next.

Cash Is King

Free cash flow isn't a prominently featured metric in company financials and earnings releases, but we think it's telling because it accounts for all operating and capital expenses, making it tough to manipulate. Cash is king.

Altria has shown terrific cash profitability, driven by its lucrative business model that enables it to reinvest, return capital to investors, and stay ahead of the competition. The company’s free cash flow margin was among the best in the consumer staples sector, averaging an eye-popping 40.8% over the last two years.

Key Takeaways from Altria’s Q1 Results

We were impressed by how significantly Altria blew past analysts’ revenue and EPS expectations this quarter. On the other hand, its gross margin missed. Overall, we think this was a decent quarter with some key metrics above expectations. The market seemed to focus on the negatives, and the stock traded down 2.1% to $56.92 immediately after reporting.

Big picture, is Altria a buy here and now? What happened in the latest quarter matters, but not as much as longer-term business quality and valuation, when deciding whether to invest in this stock. We cover that in our actionable full research report which you can read here, it’s free.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10